Carbohydrate-based adjuvants activate tumor-specific Th1 and CD8+ T-cell responses and reduce the immunosuppressive activity of MDSCs-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Carbohydrate-based adjuvants activate tumor-specific Th1 and CD8+ T-cell responses and reduce the immunosuppressive activity of MDSCs

Published:2019-01 Issue: Volume:440-441 Page:94-105
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Xu Xiaojing,Jin Ziqi,Liu Yonghao,Gong Huanle,Sun Qing,Zhang Weidong,Zhao Lixiang

Funder

National Natural Science Foundation of China

Natural Science Fund of Jiangsu Province

Open Project Program of Jiangsu Key Laboratory of Zoonosis (R1601)

Priority Academic Program Development of Jiangsu Higher Education Institutions

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference39 articles.

1. Genetically targeted T cells eradicate established breast cancer in syngeneic mice;Wang;Clin. Canc. Res.,2009

2. Bystander killing of cancer requires the cooperation of CD4(+) and CD8(+) T cells during the effector phase;Schietinger;J. Exp. Med.,2010

3. Redirecting the focus of cancer immunotherapy to premalignant conditions;Young;Cancer Lett.,2017

4. The age of vaccines;Scully;Nature,2014

5. Strategies for designing and optimizing new generation vaccines;Berzofsky;Nat. Rev. Immunol.,2001

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in protein subunit vaccines against tuberculosis;Frontiers in Immunology;2023-08-15

2. "Open Sesame" to the complexity of pattern recognition receptors of myeloid-derived suppressor cells in cancer;Frontiers in Immunology;2023-02-22

3. Toll-like receptor-targeted anti-tumor therapies: Advances and challenges;Frontiers in Immunology;2022-11-21

4. Therapeutic targets and biomarkers of tumor immunotherapy: response versus non-response;Signal Transduction and Targeted Therapy;2022-09-19

5. Multifaceted glycoadjuvant@AuNPs inhibits tumor metastasis through promoting T cell activation and remodeling tumor microenvironment;Journal of Nanobiotechnology;2021-11-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3